HINOON Stock Overview
Highnoon Laboratories Limited, together with its subsidiaries, manufactures, imports, sells, exports, and markets pharmaceutical and allied consumer products.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
Highnoon Laboratories Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | PK₨555.56 |
| 52 Week High | PK₨584.00 |
| 52 Week Low | PK₨322.10 |
| Beta | 0.34 |
| 1 Month Change | 8.32% |
| 3 Month Change | 9.24% |
| 1 Year Change | 53.96% |
| 3 Year Change | 25.49% |
| 5 Year Change | 216.02% |
| Change since IPO | 15,507.58% |
Recent News & Updates
Recent updates
Shareholder Returns
| HINOON | PK Pharmaceuticals | PK Market | |
|---|---|---|---|
| 7D | 4.2% | 2.2% | 1.8% |
| 1Y | 54.0% | 38.6% | 58.0% |
Return vs Industry: HINOON exceeded the PK Pharmaceuticals industry which returned 38.6% over the past year.
Return vs Market: HINOON underperformed the PK Market which returned 58% over the past year.
Price Volatility
| HINOON volatility | |
|---|---|
| HINOON Average Weekly Movement | 5.5% |
| Pharmaceuticals Industry Average Movement | 5.7% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in PK Market | 8.1% |
| 10% least volatile stocks in PK Market | 3.5% |
Stable Share Price: HINOON has not had significant price volatility in the past 3 months.
Volatility Over Time: HINOON's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | 2,295 | Adeel Haider | www.highnoon-labs.com |
Highnoon Laboratories Limited, together with its subsidiaries, manufactures, imports, sells, exports, and markets pharmaceutical and allied consumer products. It offers products in various therapeutic areas, including allergy, anti-infective, cardiology, gastroenterology, metabolic, musculoskeletal, obstetrics and gynecology, pediatrics, respiratory, and urology; and generic products under various brands. It serves Pakistan, Afghanistan, the United Arab Emirates, France, Kenya, Iraq, Cambodia, Tanzania, and internationally.
Highnoon Laboratories Limited Fundamentals Summary
| HINOON fundamental statistics | |
|---|---|
| Market cap | PK₨29.14b |
| Earnings (TTM) | PK₨2.45b |
| Revenue (TTM) | PK₨19.77b |
12.0x
P/E Ratio1.5x
P/S RatioIs HINOON overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HINOON income statement (TTM) | |
|---|---|
| Revenue | PK₨19.77b |
| Cost of Revenue | PK₨10.37b |
| Gross Profit | PK₨9.40b |
| Other Expenses | PK₨6.95b |
| Earnings | PK₨2.45b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 46.20 |
| Gross Margin | 47.55% |
| Net Profit Margin | 12.38% |
| Debt/Equity Ratio | 9.7% |
How did HINOON perform over the long term?
See historical performance and comparison